Drug shortage
Extended Release · Par Health, Inc.
FDA drug shortage · To Be Discontinued · updated Apr 29, 2026
Key facts
| Generic name | Extended Release, Lamotrigine Tablet |
|---|---|
| Company | Par Health, Inc. |
| Presentation | Lamotrigine, Tablet, Extended Release, 250 mg (NDC 49884-604-11) |
| Dosage form | Tablet |
| Status | To Be Discontinued |
| Therapeutic category | Neurology |
| Package NDCs | 49884-604-11 |
| First posted | Apr 29, 2026 |
| Last updated | Apr 29, 2026 |
| Discontinued | Apr 29, 2026 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: